Number of the records: 1
rivaroxaban
SYS d000069552 LBL 00000ny--a2200181n--4500 005 20250606221750.6 008 160101|-|anznnbabn-----------|-a|a------ 040 $b slo $a BA006 $d BA006 065 $a D02.886.778.727 065 $a D03.383.533.640.713 065 $a D03.383.903.727 066 $a 01 $c 03 150 $a rivaroxaban $x AA $x AD $x AE $x AG $x AI $x AN $x BL $x CF $x CH $x CL $x CS $x EC $x HI $x IM $x IP $x ME $x PD $x PK $x PO $x RE $x SD $x ST $x TO $x TU $x UR $2 slo 450 $w v $a BAY 59-7939 $2 slo 550 $7 sllk_us_auth*d065427 $Y Factor Xa Inhibitors $w P $a inhibítory faktora Xa 665 $a 2016 (2005) $2 eng 680 9-
$i A morpholine and thiophene derivative that functions as a FACTOR XA INHIBITOR and is used in the treatment and prevention of DEEP-VEIN THROMBOSIS and PULMONARY EMBOLISM. It is also used for the prevention of STROKE and systemic embolization in patients with non-valvular ATRIAL FIBRILLATION, and for the prevention of atherothrombotic events in patients after an ACUTE CORONARY SYNDROME. $2 eng 750 $a Rivaroxaban $2 eng 980 $x M
Number of the records: 1